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Summary Rats were prepared surgically so that peripheral intestinal lymph could be collected from them
while a syngenieic tumour (the HSN sarcoma) was growing in each major Peyer's patch of the small intestinie.
Dendritic lymph cells were isolated from the lymph and injected i.p. into naive, syngeneic rats. Each of the 16
recipients received just under 106 such cells and was challenged 10 days later with a subcutanieous dose of 104
viable HSN cells. Six weeks after this challenge only 7 of the recipients had a tumour anid these \vere small
(mean weight 1.8g), while 17 controls (which had each been treated with 106( thoracic duct lymphocytes from
the same donors, and given the same challenge) all had large tumours (mean weight 8.8g). The remaining 9
test rats were still free of tumours when they were killed and autopsied 4 months after challelnge.
Dendritic lymph cells from normal rats were senlsitised' by incubating them overnight on a monolayer- of
HSN cells. They were then tranisferred to 5 naive recipients which received the usual challenge. Six weeks later
they all had tumours (mean weight 1.3g) but these were much smaller than those in the 5 controls (mean
weight 9.3 g).
The occurrence in peripheral lymph of free-floating, non-
lymphoid, mononuclear cells with a dendritic morphology
was noted first by Morris (1968); he described their
morphological and ultrastructural features, and emphasised
the intimate but transient contacts they made with small
lIymphocytes. This fact, together with the relative abundance
of dendritic cells in lymph coming from allografts (Pedersen
& Morris, 1970) and the necessity of peripheral lymph for
the induction of contact sensitivity (Frey & Wenk, 1957),
suggested that these cells might be important in the
presentation of antigens, particularly in cell mediated
responses (Hall, 1971). However, decisive experiments were
hard to do in the outbred animals in which these phenomena
had been demonstrated. Steinman and Cohn (1973) obtained
appairently similar cells from the peripheral lymphoid organs
of mice, and performed a series of experiments which
showed that dendritic cells had important accessory and
antigen-presenting functions in viva) and in vitro (Steinman &
Nussenzweig, 1980). The role of such cells in the context of
tumour immunology is uncertain.
By excising the mesenteric lymph nodes from experimental
animals, and then collecting intestinal lymph sometime later
when the lymphatics have repaired themselves, it is possible
to obtain peripheral intestinal lymph which, like peripheral
lymph from any source (Smith et al., 1970), contains
dendritic cells (Hall cet al., 1977). This can be done in rats
bearing intestinal tumours (Moore et al., 1982; Gyure, et al..
1985) and this type of preparation has allowed us to collect
dendritic cells coming directly from the area of tumour
growtll. The ability of such cells to induce anti-tumour
immunity after adoptive transfer to naive recipient rats is the
subject of the experiments reported below.
Materials and methods
GenCera il exvperimnental clesign
Young (5-6 weeks old) male hooded rats were subjected to
mesenetric lymphadenectomy so that 6-8 weeks later, after
they had attained adult weight (200-250 g), the lymphatic
vessels had regenerated and the thoracic duct contained
peripheral, intestinal lymph with 1-5 percent of
macr-ophages and dendritic cells.
Rats prepared in this way were operated upon and a total
of 1(6 cells of a syngeneic sarcoma (designated HSN,c) were
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injected into the Peyer's patches in divided doses. Two weeks
later- each patch that hald received an injection was the site Of
a tumouLr - 5 mm in diameter. At this time the thoracic ducts
ol' the tumour-bearing rats were cannulated and the riats
were placed in Bollman cages so that the lymph could be
collected quantitatively for the next five days. Each morning
the lymph from several donor rats was pooled and the cells
centrifuged over a layer of Nycodenz (S.G. 1.065); the
dendritic cells and macrophages remained at the interface,
from which they were collected by aspiration, after the
lymphocytes and other cells had sunk through the Nycodenz
and formed a pellet at the bottom of the tube. The cells thus
collected were incubated overnight in plastic culture flasks so
that conventional macrophages and any tumour cells (Gyure
et al., 1985) adhered to the bottom of the flask. By gently
decanting the supernatant fluid it was possible to obtain a
population of dendtritic cells contaminated by nothing more
than a few lymphocytes. The dendritic cells were counted
and divided into equal portions according to the number of
recipients. Each portion was then injected intraperitoneally
into a normal male hooded rat. Usually, each portion
contained -2 x I05 dendritic cells so that, in the 5 day
period, each recipient was given a total of about 106. Ten
days after the last injection the recipients received a
challenge dose of 104 HSNtC cells, given subcutaneously into
the right flank and were observed every other day or so for
the growth of a tumour at the injection site. Control rats
received ordinary lymphocytes obtained from the pelleted
lymph cells, these were given in the same numbers and by
the same route as the dendritic cells. The control rats
received the same challenge of 104 cells from the same
preparation of tumour cells that was used to challenge the
test animals.
A smaller, complementary series of experiments was done
in which an attempt was -mde to 'sensitize' dendritic cells to
tumour cells in vitro. Th'e dendritic cells were harvested from
normal, non-tumour bearing rats as described above, and
then incubated overnight on a monolayer of HSNtc cells.
The dendritic cells were then decanted, counted and injected
into naive recipients in exactly the same way as in the first
part of the experiment; the same challenge of tumour cells
was given, and the same type of controls were used.
Animnals, tliaIours anId surgical procedures
Specific pathogen free CBH/Cbi (RT1') rats were taken from
our own colony, which is maintained in positive pressure
isolators.
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The tumour used was in all cases the HSN, a
transplantable sarcoma induced originally (1968) with a
pellet (s.c.) of 3,4 benzpyrene. This tumour is antigenic and
potentially metastatic, and has been the subject of several
publications (e.g., Currie & Gage, 1973; Gyure et al., 1980;
Eccles, 1982). Cells from this tumour were first grown in
culture 9 years ago and a cloned line, designated HSNtc was
established and has formed the basis of much of our work.
It has shown little variation in behaviour but as a routine we
discard cells that have been passaged in vitro more than 20
times, and start a fresh culture from banked cells. The cells
used in the present study had been passaged 7 times in vitro
and reacted normally with the appropriate syngeneic,
monoclonal antibody (North et al., 1982). Although the
tumour is antigenic it can grow and kill from 102 cells.
Active immunity is induced best by injecting 106 cells into
one hind leg and amputating it after 14 days of tumour
growth. Rats treated in this way can reject a dose of 105-106
viable cells and have tumour specific antibodies in their
serum.
The surgical techniques, care of the cannulated animals,
and the collection of lymph were carried out by standard
methods which have been described (Styles et al., 1984;
Gyure et al., 1985).
solation of dendritic cells ancl( cell culture methods
Lymph was collected in bottles containing sterile heparinsed
Eagles Minimum Essential Medium (MEM) with 2 mM
HEPES. Lymph cells were concentrated by centrifugation
(1500r.p.m. for 5min in a bench centrifuge), washed once in
MEM+5% foetal bovine serum (FBS) and resuspended in
medium to a concentration of 1-2 x 107 ml- 1. Approximately
I ml vol of Nycodenz (Nyegaard, Oslo) were overlayered
with 2 vol of cell suspension in 12 x 75 mm sterile plastic
tubes and the tubes subsequently spun for 10min at
2000 r.p.m. at room temperature. Cells removed from the
interphase were washed once, resuspended in MEM with 5%
FCS and transferred to 30ml plastic tissue culture flasks.
The flasks, each of which contained 5 x 101-106 cells in 5ml
medium, were incubated overnight at 37"C in a humidified
atmosphere containing 5% CO2.
Assayiol'ftunoul- growtth
The sites of injection of the challenge dose in the
subcuticulum of the rats' flanks were palpated 3 times a
week. In control rats an unequivocal nodule of 1-2mm is
usually palpable within 4-5 weeks. The time at which each
tumour first became detectable was noted and observation
continued. When the tumours in the control rats became
very large (up to 15 g) the rats were killed, and their tumours
excised, weighed and submitted to histological examination.
At the same time any test rats that had palpable tumours
were dealt with in the same way. Sixteen weeks after the
initial challenge dose of tumour any surviving tumour-free
rats were killed and submitted to necropsy.
Cell counits
Counts of the total white cells in lymph and other
suspensions of cells were performed by direct microscopy in
a Neubauer chamber after appropriate dilution in 1.5%
acetic acid.
Differential counts were made by inspecting living cells
under a coverslip using a x 100 objective and phase contrast
optics. The non-lymphoid mononuclear cells in peripheral
lymph are comprised of a spectrum of cells ranging from
classical dendritic cells (which tend to be non-adherent and
non-phagocytic in in vitro systems) to conventional
macrophages which have a less ebullient hyaloplastic
membrane, are often replete with ingested detritus, and
adhere firmly to glass and plastic. In the present study the
incubation step in the cell isolation procedures ensured that
Figure I Photomicrograph (phase contrast, approx. x 1700) of
living dendritic macrophage from the peripheral intestinal lymph
of a rat bearing a syngeneic sarcoma in the small intestine. Note
the juxta-nuclear cytoplasmic vacuoles and the ebullient
hyaloplastic membrane; a small lymphocyte is shown also.
the great majority of cells injected were of the dendritic
phenotype. A photomicrograph of a dendritic macrophage is
shown in Figure 1.
Results
The first series of experiments involved 16 test rats, 17
control rats and 16 donor rats. The donor rats had had their
mesenteric nodes removed and had had HSNtC cells injected
into their Peyer's patches; the dendritic cells isolated later
from their thoracic duct lymph were injected into the test
rats, in an attempt to induce anti-tumour immunity before
challenge with viable HSNtc cells. On average each test rat
received 9.3 x 105 dendritic cells, the range being from 8 to
12 x I05. The control rats received the same number of
thoracic duct lymphocytes from the same donors. The effect
of these treatments on the consequences of the challenge
with 104 viable HSNtC cells is shown graphically in Figure 2.
It can be seen that 5 weeks after the challenge dose of the
tumour, all the control rats had unequivocal tumours but
more than half (9/16) of the test rats were tumour free. Six
weeks after challenge some of the tumours in the control rats
were already massive, so all tumour bearing rats, test and
control, were killed and their tumours were excised and
weighed. The mean weight of the tumours from the 17
control rats were 8.81 g+0.73, and the mean weight of the
tumours from the 7 test rats were 1.86g±0.39. The
remaining 9 test rats remained tumour free and were killed
16 weeks after the challenge dose; no trace of tumour was
found at the injection site, or in any other part of the rats.
The rate of growth of the tumours in the control rats was
similar to that of historical controls that had received no
treatment. Also, an additional 3 control rats, used at the
start of the present series, received no treatment before
tumour challenge, and all developed large tumours at the
same rate as the later, formal controls which received
lymphocytes.
The second series of experiments was smaller; a total of 15
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Figure 2 Graph to show the occurrence of palpable tumours in
rats after 104 HSNIC syngeneic sarcoma cells had been injected
s.c. into their right flanks at time zero. The test rats ( ) had
received previously about 106 dendritic macrophages from
syngenieic tumour bearing donors. The controls (.) had
received the same number of thoracic duct lymphocytes from the
same donors.
groups. Dendritic cells were collected from the lymph of
non-tumour bearing donors and incubated overnight with a
monolayer of HSNtC cells. The dendritic cells were then
decanted and injected i.p. into naive recipients as before. The
output of dendritic cells in the lymph of the tumour-free
donors was found to be substantially greater than that of
their tumour-bearing counterparts, and enabled an average
total dose of 3.15 x 106 dendritic cells (range 0.5-6.5 x 106)
to be given. In spite of this larger dose, the effects on the
subsequent growth of the challenge dose of tumour were less
obvious. The times at which the tumours first became
detectable did not differ between the tests and controls, and
all the rats were killed after six weeks. Nonetheless, the
weights of the tumours in the test animals were much less
than in the controls, 1.30g+0.96 vs. 9.30g+2.73.
In both series, histological examination of the tumours
confirmed that they had retained their usual characteristics.
No significant differences between the tumours in the test
and control animals were seen.
Discussion
The results show that dendritic mononuclear cells collected
from the lymphatic effluent of tumour bearing tissues were
able to induce a state of increased resistance to the tumour
in naive, syngeneic recipients. That such an effect was
achieved by the transfer of so few cells is a finding that is
without precedent in the experimental history of this tumour.
Conventional attempts to adoptively transfer immunity with
thoracic duct lymphocytes have never been consistently
successful, even when up to 10' such cells were transferred.
However, altlhough the present results ar-e encouraging they
must be regarded as preliminary. We have not yet performed
formal, control experiments to demonstrate specificity, e.g.
the transfer of dendritic cells that have been in contact with
an unrelated tumour, or no tumour at all. Experiments
involving lymph-borne dendritic cells are expensive of time
and animals, and a comprehensive study has yet to be
undertaken. It is likely, though, that the observed immunity
was tumour specific; such an efficient mechanism could
hardly operate in any other way. and our working
hypothesis is that the transferred cells acted as hyper-
efficient presenters of tumour specific transplantation
antigen(s). Certainly, we have found no evidence at all in in
vitro systems, that dendritic cells have direct cytotoxic effects
on any type of tumour cell, even in the presence of specific
anti-tumour antibody. This, together with the previously
cited work, suggests that antigen presentation was
responsible for the observed results but we have yet to define
precisely the optimum times for collecting the dendritic cells
from the donors and for giving the tumour challenge to the
recipients, and we do not know how long the immunity lasts.
This information can only come from more experiments,
which would be easier to design if the natural history of
dendritic cells were better understood. Such cells are
conspicously absent from intermediate, central lymph and
blood but are known to be present in the peripheral lymph
of sheep (op. cit), rabbits (Kelly et al., 1978), pigs (Mefarlin
& Balfour, 1973) and man (Spry et al., 1980) as well as the
peripheral lymph of rats. Apparently identical cells can be
cultured from human peripheral blood mononuclear cells
(Knight et al., 1986) and we have been able to prepare them
from the peripheral blood of sheep by similar methods. The
exact nature and lineage of dendritic cells is controversial.
We believe that they belong to the monocyte-macrophage
series because in vivo they phagocytose carbon (Morris,
1968), red cells (Hall, 1979) and immune complexes (Hall &
Robertson, 1984). Their generally non-adherent and non-
phagocytic nature in in vitro systems (which may be caused
partly by the anticoagulants necessary for their collection)
could be one reason why our attempts to "sensitize' them to
the tumour in vitro were only partially successful.
It may be significant that the lymph from tumour bearing
rats contained fewer of these cells than that from non-
tumour bearers. Conceivably, many of the dendritic cells
were pre-occupied in the tumour tissue, and were less able to
gain entry into the lymph. Previous experiments have shown
that rat sarcomata are able to sequester cells of the
monocyte-macrophage series and cause a deficit of such cells
at other sites (Eccles & Alexander, 1974).
Clearly, there is much to be learned about these cells but
their ability to operate effectively in small numbers is
unsettling as well as exciting. If, as Steinman and his
colleagues report, such cells are present in most peripheral
lymphoid organs, how many of the phenomena of
transplantation and tumour biology, previously attributed to
lymphocytes prepared from such sources, are really due to
the tiny minority of dendritic macrophages that inevitably
must have been present?
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